Literature DB >> 18606078

Recent advances in immunotherapy of allergic rhinitis.

Chul Hee Lee1, Ji-Hun Mo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18606078     DOI： 10.1007/s11882-008-0044-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


× No keyword cloud information.
  15 in total

1.  Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.

Authors:  Calman Prussin; Daniel T Griffith; Kevin M Boesel; Henry Lin; Barbara Foster; Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

Review 2.  Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.

Authors:  Holger Kanzler; Franck J Barrat; Edith M Hessel; Robert L Coffman
Journal:  Nat Med       Date:  2007-05       Impact factor: 53.440

3.  Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

Authors:  J B Sun; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

4.  Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis.

Authors:  Ji-Hun Mo; Seok-Won Park; Chae-Seo Rhee; Kenji Takabayashi; Seung Sin Lee; Song-Hua Quan; In-Sang Kim; Il Yang-Gi Min; Eyal Raz; Chul Hee Lee
Journal:  Am J Rhinol       Date:  2006 Mar-Apr

5.  Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients.

Authors:  V Di Rienzo; A Pagani; S Parmiani; G Passalacqua; G W Canonica
Journal:  Allergy       Date:  1999-10       Impact factor: 13.146

Review 6.  Sublingual Immunotherapy: Past, present, paradigm for the future? A review of the literature.

Authors:  Bryan D Leatherman; Sara Owen; Mike Parker; Stephen Chadwick; John A Fornadley; Doug Colson; Paul Fass
Journal:  Otolaryngol Head Neck Surg       Date:  2007-03       Impact factor: 3.497

7.  Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy.

Authors:  Michela Silvestri; Daniela Spallarossa; Elena Battistini; Federica Sabatini; Silvia Pecora; Silvano Parmiani; Giovanni A Rossi
Journal:  J Investig Allergol Clin Immunol       Date:  2002       Impact factor: 4.333

Review 8.  The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.

Authors:  Philippe Stock; Claudia Rolinck-Werninghaus; Ulrich Wahn; Eckard Hamelmann
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

Review 9.  Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.

Authors:  Sandip K Datta; Hearn J Cho; Kenji Takabayashi; Anthony A Horner; Eyal Raz
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

10.  The effect of omalizumab on nasal allergic inflammation.

Authors:  Halina Plewako; Monica Arvidsson; Karin Petruson; Iolanda Oancea; Kenneth Holmberg; Ellinor Adelroth; Hans Gustafsson; Thomas Sandström; Sabina Rak
Journal:  J Allergy Clin Immunol       Date:  2002-07       Impact factor: 10.793
View more
  1 in total

Review 1.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.